Capricor Therapeutics accuses Nippon Shinyaku of slow-walking Duchenne drug
Capricor Therapeutics accused Nippon Shinyaku and its U.S. subsidiary of failing to follow through on marketing plans for…
FDA to review data in real time, SCOTUS hears ‘skinny label’ case
Top of the morning to you. The middle of the week is upon us and, since you made…
AI could check millions of lung cancer scans for heart risk. Who will pay for it?
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
Medicare’s ACCESS chronic care pilot signs up 150 companies
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
Hospitals launch chatbots, creating another funnel for patient intake
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
A mother’s 20-year quest fuels a startling Duchenne breakthrough
A year after the worst day of her life, Debra Miller received a voicemail she couldn’t quite make…
Study finds missed opportunities for targeted cancer treatments
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT…
U.S. health care system must become fully autonomous
About 20 years ago, I stepped on stage at one of our Geisinger town halls and looked out…
What does UnitedHealth Group’s massive AI push mean for patients?
From a scan of its job openings, it would be easy to mistake UnitedHealth Group for Silicon Valley’s…
Large AI scribe study finds modest time savings, inconsistent use
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
Health care giants are trimming jobs, not driving employment growth
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
AI Prognosis: A 2023 health AI bet that seems to be paying off
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health…